Our PBC Awards Programme encourages the development of innovative projects which aim to improve the lives of people living with primary biliary cholangitis (PBC).
We have already supported projects over three award cycles, with projects including learning platforms for physicians, peer-to-peer support analyses, cost-effective platforms to link patients through existing national frameworks, analyses of existing data to identify those undiagnosed, educational apps for the patient community, and many more!
Launched in 2016, Practice to Policy® supports local, innovative ideas that form a basis for best practice, which can be adapted more broadly. At its heart, Practice to Policy® is about sharing learnings that inspire change – what worked well, what didn’t, and what can we learn as an entire community to inform care. The projects supported under this programme are independent of the use of any particular therapeutic agent. Applications are then admitted according to specific criteria.
The Europe and Canada Practice to Policy® Health Awards Programme is endorsed by the European Association for the Study of the Liver (EASL).
Eligibility criteria for 2019: Collaborative care
The Practice to Policy® Health Awards Programme in primary biliary cholangitis (PBC) encourages the development of innovative projects, which are designed to improve the lives of people living with PBC.
In 2019, we focused on local and national projects that pioneered collaborative care between healthcare professionals and people living with PBC. Specifically, we sought projects that:
In 2019, Intercept funded nine new innovative projects, with no one application being greater than €25,000 (or local currency equivalent).
In addition to this, and new for 2019, Intercept provided two additional funding awards (up to €15,000 or local currency equivalent) to projects that replicated previous Practice to Policy® winners.
